RPB0411

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
Influenza A virus (H1N1) Influenza A virus (A\WSN\1933(H1N1)) 382835 Articulavirales Orthomyxoviridae Alphainfluenzavirus Influenza A virus Virus

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
F4-Primer CAAAAGATCACATTGGCACCCGCAATCCTG 30 10 μM 50 64.1 9129.01 \
R4-Primer Bio-T*C*T*T*G*AACTGTTGCGACTACGTGATGAGGAA 31 10 μM 45.16 62.53 9670.59 \

Gene Description

Target Gene GenBank ID
N gene NC_019843.3

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
showing great potential in response to future pathogen-based pandemics. RPA-TeaPNA-LFA \ 4+16min 37°C TeaPNA-LFA 6.7 copies/μL of RNA and 90 copies/μL of virus 1 1

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2023 Specific lateral flow detection of isothermal nucleic acid amplicons for accurate point-of-care testing Ting Zheng, Xianming Li, Yanjun Si, Minjin Wang, Yuzhen Zhou, Yusheng Yang, Na Liang, Binwu Ying, Peng Wu Biosensors & Bioelectronics 36538868 10.1016/j.bios.2022.114989

Specific lateral flow detection of isothermal nucleic acid amplicons for accurate point-of-care testing

Author(s):

Ting Zheng, Xianming Li, Yanjun Si, Minjin Wang, Yuzhen Zhou, Yusheng Yang, Na Liang, Binwu Ying, Peng Wu

Journal:

Biosensors & Bioelectronics

Year:

2023

Abstract:

For point-of-care testing (POCT), coupling isothermal nucleic acid amplification schemes (e.g., recombinase polymerase amplification, RPA) with lateral flow assay (LFA) readout is an ideal platform, since such integration offers both high sensitivity and deployability. However, isothermal schemes typically suffers from non-specific amplification, which is difficult to be differentiated by LFA and thus results in false-positives. Here, we proposed an accurate POCT platform by specific recognition of target amplicons with peptide nucleic acid (PNA, assisted by T7 Exonuclease), which could be directly plugged into the existing RPA kits and commercial LFA test strips. With SARS-CoV-2 as the model, the proposed method (RPA-TeaPNA-LFA) efficiently eliminated the false-positives, exhibiting a lowest detection concentration of 6.7 copies/μL of RNA and 90 copies/μL of virus. Using dual-gene (orf1ab and N genes of SARS-CoV-2) as the targets, RPA-TeaPNA-LFA offered a high specificity (100%) and sensitivity (RT-PCR Ct < 31, 100%; Ct < 40, 71.4%), and is valuable for on-site screening or self-testing during isolation. In addition, the dual test lines in the test strips were successfully explored for simultaneous detection of SARS-CoV-2 and H1N1, showing great potential in response to future pathogen-based pandemics.